Ventyx Biosciences (NASDAQ:VTYX) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.44) by 34.09 percent. This is a 81.39 percent increase over losses of $(3.17) per share from the same period last year.
“Agilysys POS Platform Approved For Marriott International Properties In U.S. And Canada”
https://www.agilysys.com/en/agilysys-pos-platform-approved-for-marriott-international-properties-in-u-s-and-canada/ – Cloud-Native InfoGenesis® Point-of-Sale Platform Approved as Option Across Marriott's
